iNtRODUCtiON
Polymorphous low-grade adenocarcinoma (PLGA) is a rare, slow-growing, malignant epithelial tumour of the salivary gland that typically occurs in the oral cavity, particularly the hard palate. It is distinguished from other adenocarcinomas of salivary gland origin.
1,2 Its tumour cells are characterised by infiltrative borders with highly variable growth patterns that include tubular, solid, cribriform, trabecular, fascicular, and papillarycystic formations. This multicomponent histology makes PLGA difficult to distinguish from pleomorphic adenomas and adenoid cystic carcinomas.
3,4
Standard of care is wide local excision. PLGA has a low risk of regional node or distant metastases so elective neck dissection is usually not performed. 5, 6 Adjuvant radiotherapy (RT) is indicated in patients with positive margins or high-risk features such as nerve invasion. Primary RT is preferred in inoperable patients because of tumour size or medical co-morbidities. 7 PLGA usually presents as an indolent asymptomatic growth with low malignant potential; RT doses range from 66 Gy for microscopic disease to 70 Gy for gross residual disease. 8 We reviewed the clinical course and outcome of patients who underwent RT for PLGA of the head and neck.
MEtHODS
This study was approved by the institutional review board of our hospital and conducted in compliance with Declaration of Helsinki. We retrospectively reviewed medical records of patients who underwent RT for PLGA of the head and neck at our institution between June 1993 and March 2013.
RESUltS
Two men and two women aged 43 to 76 years who underwent primary (n = 1) or postoperative (n = 3) RT for PLGA of the oropharynx (soft palate; n = 2) or oral cavity (hard palate; n = 2) were reviewed (Table) . No patient had regional lymph node involvement or distant metastasis at the time of diagnosis.
Three patients underwent resection: one had close margins, one had microscopically positive margins, and the other had negative margins but perineural invasion. One patient with a hard palate tumour involving the pterygoid plate underwent RT alone (79.2 Gy, 66 fractions twice daily) because the lesion was thought to be not completely resectable due to its size and location. Intensity-modulated RT (n = 2) or 3-dimensional RT (n = 2) was performed with dose ranging from 60 to 79.2 Gy in 30 fractions once daily (n = 1) to 60-66 fractions twice daily (n = 3).
Patients were followed up every 2 to 3 months for the first 2 years, every 4 months for the third year, every 6 months for the fourth and fifth years, and yearly thereafter. Chest radiography was taken annually. Computed tomography was taken when physical examination showed suspicious findings. Local control was defined as no evidence of disease at the primary site.
Patients were followed up for 13 months to 9.5 years; none was lost to follow-up. Disease-free local control was achieved in the three patients treated with both surgery and postoperative RT. The patient treated with RT alone had recurrence at level 2 lymph nodes at 3 months, and then at the nasal lacrimal duct extending into the medial canthus and the right orbit at 6 months, and then at the 11th rib at 11 months. The patient received supportive care and subsequently died of disease progression. No patient developed severe acute or late treatment-related toxicity.
DiSCUSSiON
Wide local excision is the preferred treatment for PLGA. 6 Patients with negative or even close margins and no adverse features should be followed up regularly as local recurrence may take years to develop.
5 Lymph node metastasis is unlikely and thus elective neck dissection is unnecessary.
In a retrospective study of 460 patients, margin-free 腫瘤的患者僅接受放療治療。調強放療（n = 2）或三維放療（n = 2）以30份每日一次（n = 1）至 60-66份每日兩次（n = 3）進行；總劑量為60至79.2 Gy。患者隨訪期為13個月至9.5年。3名接受手 術和術後放療的患者實現了無病局部控制。僅接受放療治療的患者3個月後出現復發，最終因病情惡 化死亡。沒有患者發生嚴重急性或晚期治療相關中毒。 結論：術後放療可改善陽性或近切緣PLGA的局部控制。 surgery correlated with a 10-year overall survival rate of 98%. 7 The overall survival rate was higher in patients with surgery followed by postoperative RT (94%) and surgery alone (92%), compared with RT alone (75%).
7
Although negative margins following resection is the best prognostic factor, a non-morbid surgery is not always feasible because of the location and extent of the tumour.
7,9,10
The role of RT in treatment of PLGA remains unclear. 7, 11 Patients with positive margins, high-risk features, or inoperable tumours are usually referred for RT.
7 In a study of 40 patients with PLGA followed up for a minimum of 10 years, those who underwent surgery with positive or unknown margins followed by postoperative RT had fewer recurrences, with a local control rate of 100% after 10 years. 4 In a study of 164 patients with PLGA, 15 of 17 patients treated with postoperative RT had no evidence of disease.
11
Those treated with RT alone had an increased rate of recurrence but a comparable survival rate compared with those treated with surgery alone.
11 Nonetheless, there may have been selection bias favouring the surgery-alone group. Two patients declined surgery, and it is unclear why other patients underwent RT alone.
In our patient treated with RT alone (79.2 Gy in 66 fractions twice daily), hyperfractionation was used as it has been used for squamous cell carcinomas of the head and neck.
12, 13 The short disease-free interval and both regional and distant recurrences suggest that the tumour was a biologically more aggressive malignancy despite histologically consistent with a PLGA.
CONClUSiON
Postoperative RT may improve local control of PLGA in patients with close or positive margins after surgery.
